Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Multiomics Market From 2025 To 2029?

In the past few years, the multiomics market has expanded significantly. Its size is projected to increase from $3.27 billion in 2024 to $3.85 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. Several factors have contributed to this historic period of growth, such as the surge in biomedical research, increased governmental and private financial support, a higher incidence of chronic illnesses, advances in technology, and improvements in computational tools and software used for data analysis.

What Is the Projected Market Size of the Multiomics Market?

Anticipated for rapid ascension in the near future, the multiomics market is projected to escalate to $7.38 billion by 2029 with a compound annual growth rate (CAGR) of 17.6%. This expansion in the projected timeframe is credited to advancements in artificial intelligence and machine learning, broadening clinical application scopes, the growth of the biopharmaceutical sector, the rise in integrated multiomics platforms, and their amplified utilization in agriculture and environmental studies. The forecast period will also observe significant trends such as technological progressions, the introduction of new commercial multiomics platforms, the embrace of spatially resolved multiomics analysis, its application in biopharmaceutical investigation and development, and proliferation into clinical diagnostics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

Who are the Major Competitors in the Multiomics Market Outlook?

Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

What Is Fueling Growth in the Multiomics Market?

The burgeoning need for tailor-made medicine is anticipated to push forward the progress of the multiomics market. Tailor-made medicine implies a healthcare proposition that individualizes medical decisions and treatments, depending on a patient’s genetic makeup, environmental factors, and lifestyle habits. There’s an increasing tendency towards this approach due to the progression of technology, growing requirement for targeted treatments, and enhancements in worldwide healthcare. Multiomics contribute to personalized healthcare by offering an extensive perception of a patient’s genetic, molecular, and metabolic layout. This enables healthcare professionals to devise treatments aligning with the distinct features of each patient. As an example, let’s take February 2024. The Personalized Medicine Coalition, a not-for-profit organization based in the US, stated that the FDA sanctioned 16 unique personalized treatments in 2023 for patients suffering from rare illnesses. This is a significant increase compared to 6 in 2022. So, it’s clear that the escalating demand for tailor-made medicine is fueling the expansion of the multiomics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Which Multiomics Market Segments Are Growing the Fastest?

The multiomics market covered in this report is segmented –

1) By Type: Single-Cell Multiomics, Bulk Multiomics

2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms

3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications

4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users

Subsegments:

1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics

Which Industry Trends Are Shaping the Future of the Multiomics Market?

Leading firms in the multiomics market are innovating high-end single-cell multiomics platforms that preserve the quality of samples while conducting comprehensive studies. These platforms marry various omics technologies with the power of artificial intelligence, enabling users to smoothly delve deep into complicated biological data with smart algorithms and machine learning. For example, Becton, Dickinson, and Company, an American medical device corporation, introduced the BD Rhapsody HT Xpress in February 2023. This state-of-the-art high-throughput single-cell multiomics platform allows researchers to isolate, code, and evaluate single cells on a large scale, hosting up to eight times more cells than older BD single-cell analyzers. The BD Rhapsody HT Xpress System guarantees zero sample wastage and provides the flexibility to examine various samples and a variety of cell sizes and types like stem cells or cancer cells at the same time, thereby boosting researchers’ capability to discover more in less time.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

Which Countries Are Leading the Multiomics Market?

North America was the largest region in the multiomics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

This Report Delivers Insight On:

1. How big is the multiomics market, and how is it changing globally?

2. Who are the major companies in the multiomics market, and how are they performing?

3. What are the key opportunities and risks in the multiomics market right now?

4. Which products or customer segments are growing the most in the multiomics market?

5. What factors are helping or slowing down the growth of the multiomics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model